February 9, 2026 · Form 4 insider transaction
Sukhatme Mayukh sold 339,441 shares of Roivant Sciences Ltd. at $26.47 per share, a transaction worth $8.99M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
All options exercised by the reporting person would have expired in March 2026 if not exercised. The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.; These Common Shares were sold in multiple transactions at prices ranging from $25.92 to $26.78, inclusive.